3 FDA Approval Recommendations
In this video, health care analyst David Williamson takes a look back on the week so far for the Food and Drug Administration advisory committee. A trifecta of recommendations for approval greeted investors, although not all thumbs-ups are equal. Watch and find out what this means for investors of the three companies.
While you can certainly make huge gains in biotech and pharmaceuticals, the best investing approach is to choose great companies and stick with them for the long term. In our free report "3 Stocks That Will Help You Retire Rich," we name stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.
The article 3 FDA Approval Recommendations originally appeared on Fool.com.David Williamson holds no position in any company mentioned. Click here to see his holdings and a short bio. The Motley Fool has a disclosure policy.
We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.